Article
The T2-FLAIR mismatch sign as an imaging marker for non-enhancing IDH-mutant, 1p/19q-intact lower-grade glioma: a validation study.
Neuro-oncology - 3 Sept 2018
Broen Martinus P G, Smits Marion, Wijnenga Maarten M J, Dubbink Hendrikus J, Anten Monique H M E, Schijns Olaf E M G, Beckervordersandforth Jan, Postma Alida A, van den Bent Martin J
Abstract excerpt
Background: The purpose of this study was to assess the reproducibility of the previously described T2-fluid attenuated inversion recovery (FLAIR) mismatch sign as a specific imaging marker in non-enhancing isocitrate dehydrogenase (IDH) mutant, 1p/19q non-codeleted lower-grade glioma (LGG), encompassing both diffuse and anaplastic astrocytoma. Methods: MR scans (n = 154) from 3 separate databases with genotyped...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
